The highly anticipated hearings on cannabis rescheduling, set to begin next week, have now been cancelled in a major escalation of tensions between the Drug Enforcement Administration (DEA) and other witnesses.Â
Cannabis stocks plummeted this week after a judge ordered the Drug Enforcement Agency (DEA) to respond to damning new allegations
Reaching consensus on hotly debated issues is rare in the cannabis space, especially when it comes to potential ramifications of
The Drug Enforcement Administration (DEA) has scheduled an official date for the highly anticipated public hearing on cannabis rescheduling, starting with a presentation from the government just a day after President Elect Donald Trump is sworn in.Â
The first step in the US’s landmark efforts to reschedule cannabis officially took place yesterday, setting the stage for what is set to be a lively and heated process.Â
Following the short-lived candidacy of Matt Gaetz for US Attorney General in President elect Donald Trumps new cabinet, the outlooks
Ahead of the delayed and highly anticipated cannabis rescheduling hearings, now set to take place in early 2025, the US Drug Enforcement Administration (DEA) has suggested it could add more participants.Â
The next step in the yearslong cannabis rescheduling process could be a brief hearing where an administrative law judge informs witnesses why they aren’t qualified to participate, observers told MJBizDaily.
Written by Deb Tharp, activist and political consultant. We were on the cusp of full federal recognition of medical cannabis.
As the most consequential US election in recent history comes to close after a long and turbulent campaign, the dust is beginning to settle on the prospective outlook for cannabis under the new administration.Â
We won’t spam you
© 2024 Prohibition Holdings Ltd. All Rights Reserved.
